ArticleJournal of translational medicine2026

A dual-mechanism model of Selinexor in DLBCL: p53 reactivation and metabolic reprogramming.

Wenqi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.